Donor diabetes and cornea transplant success at 5 years
Part of Eyes & vision, Genetic & congenital clinical trials.
This study looks at how a donor's diabetes might affect the long-term success of a specific type of cornea transplant called DMEK. Participants from an earlier study (DEKS) will be followed for up to 5 years to see how well the transplant is doing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a DMEK cornea transplant as part of the DEKS study.
- You completed the 12-month follow-up in the DEKS study.
- You are willing to come back for checkups at 3 and 5 years after your transplant.
- You can speak English or Spanish.
- You are willing to have a small finger-stick blood test to check your blood sugar (HbA1c).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special intraocular lens that works with a cornea transplant procedure (DMEK) for people who have both cataracts and Fuchs' endothelial corneal dystrophy. It aims to see if this lens improves vision and reduces the need for glasses.
This trial tests an investigational eye drop (DT-168) in people with Fuchs endothelial corneal dystrophy who are already scheduled for a corneal transplant. The goal is to see if DT-168 can improve outcomes or delay the need for surgery.
This study looks at how well people do after a specific type of corneal transplant called posterior lamellar keratoplasty. It aims to understand long-term outcomes for patients who had this surgery.
This trial tests a surgical technique called Descemet membrane polishing during corneal transplant surgery for Fuchs endothelial corneal dystrophy, a condition that clouds the cornea (the clear front part of your eye). The study aims to see if this polishing step improves healing and vision after surgery.
This trial tests a new treatment, EO2002, for people with corneal swelling that causes vision loss. It aims to offer an alternative to corneal transplant for those with conditions like Fuchs dystrophy or swelling after cataract surgery.
This study tests a scoring system to predict how well people with Fuchs dystrophy do after cataract surgery. It may help doctors plan better treatment for your cornea and lens.
Hear when a new Fuchs Endothelial Corneal Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.